Sort
21,453 grants matching “tuberculosis”
Treatment of tuberculosis with immunomodulators
$390,890Brigham And Women'S Hospital · R01 · FY2004 · HL
Target Identification
$390,769Michael Niederweis · Florida State University · P01 · FY2011 · AI
Mechanism of M. tuberculosis Phagosome Maturation Arrest
$390,766Vojo P Deretic · University Of New Mexico · R01 · FY2008 · AI
Distinct pathways for MR1 antigen presentation upon infection with intracellular versus extracellular pathogens
$390,733Melanie J Harriff · Oregon Health & Science University · R01 · FY2017 · AI
M Tuberculosis CTL Epitopes: Vaccine Design/Evaluation
$390,600Carol A. Clayberger · Stanford University · R01 · FY2006 · AI
PHARMACOKINETICS AND TOXICITY OF 2ND LINE ANTI-TB DRUGS IN HIV-INFECTED CHILDREN
$390,498Anneke Catharina Hesseling · Stellenbosch University · R01 · FY2013 · HD
Systemic AA Amyloidosis Inhibitors
$390,262Alan D. Snow · Proteotech, Inc. · R44 · FY2010 · AR
DYNAMICS AND TUNING OF THE MHC II PRESENTED PEPTIDOME
$390,129Laura Santambrogio · Albert Einstein College Of Medicine · R01 · FY2018 · AI
Construction of safe and effective live tuberculosis vaccines
$390,100Steven A Porcelli · Albert Einstein College Of Medicine · R01 · FY2013 · AI
Post-translocational protein folding in Gram-positive bacteria
$390,071Hung Ton-That · University Of Texas Hlth Sci Ctr Houston · R01 · FY2017 · DE
Molecular mechanisms used by Chlamydia trachomatis to manipulate membrane fusion
$390,000Fabienne Michelle Paumet · Thomas Jefferson University · R01 · FY2019 · AI
Molecular mechanisms used by Chlamydia trachomatis to manipulate membrane fusion
$390,000Fabienne Michelle Paumet · Thomas Jefferson University · R01 · FY2016 · AI
L-citrulline and anti-tuberculosis host defense
$390,000Joseph E Qualls · Cincinnati Childrens Hosp Med Ctr · R01 · FY2018 · AI
L-citrulline and anti-tuberculosis host defense
$390,000Joseph E Qualls · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · AI
TLR2 and the Tubercle Granuloma
$390,000Padmini Salgame · Univ Of Med/Dent Of Nj-Nj Medical School · R56 · FY2010 · AI
TLR2 and the Tubercle Granuloma
$390,000Padmini Salgame · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2012 · AI
L-citrulline and anti-tuberculosis host defense
$390,000Joseph E Qualls · Cincinnati Childrens Hosp Med Ctr · R01 · FY2016 · AI
L-citrulline and anti-tuberculosis host defense
$390,000Joseph E Qualls · Cincinnati Childrens Hosp Med Ctr · R01 · FY2017 · AI
L-citrulline and anti-tuberculosis host defense
$390,000Joseph E Qualls · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · AI
Project 3: Post-transcriptional regulation of innate immunity to Legionella pneumophila
$389,968Russell E Vance · University Of California Berkeley · P01 · FY2017 · AI
Host Genetic Factors in Pediatric HIV Disease Progression
$389,941Gabriel Anabwani · Botswana Baylor Child/Clincal Ctr/Excell · U54 · FY2017 · AI
Listeria monocytogenes physiology and host pathogen interactions
$389,875Joshua Woodward · University Of Washington · R01 · FY2016 · AI
Listeria monocytogenes physiology and host pathogen interactions
$389,875Joshua Woodward · University Of Washington · R01 · FY2017 · AI
Listeria monocytogenes physiology and host pathogen interactions
$389,875Joshua Woodward · University Of Washington · R01 · FY2019 · AI
Advancing New Drug Regimens for MDR/XDR TB
$389,754Eric L Nuermberger · Johns Hopkins University · R01 · FY2010 · AI